贝达药业（300558）发行价17.57元，市盈率22.99。海通证券预计贝达药业2016-2018年摊薄后EPS分别为0.96、1.29、1.57元，参考可比公司估值情况，给予201645-55倍PE估算，公司合理股价区间为43.2-52.8元。 贝达药业（300558）新股上市分析...
Beida Pharmaceutical (300558) the issue price of 17.57 yuan, the price earnings ratio of 22.99. Haitong Securities is expected to Beida pharmaceutical 2016-2018 diluted EPS were 0.96, 1.29, 1.57 yuan, with reference to comparable valuation of the company, to give 201645-55 times PE estimates, the company a reasonable price interval for 43.2-52.8 yuan. Beida Pharmaceutical (300558) IPO analysis...
